Pharvaris NV [PHVS] stock is trading at $24.54, up 2.38%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PHVS shares have lost -4.92% over the last week, with a monthly amount glided 2.29%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pharvaris NV [NASDAQ: PHVS] stock has seen the most recent analyst activity on October 15, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $60. Previously, BofA Securities upgraded its rating to Neutral on October 09, 2025, and kept the price target unchanged to $27. On June 11, 2025, Guggenheim initiated with a Buy rating and assigned a price target of $32 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $28 on April 29, 2025. Wedbush initiated its recommendation with a Outperform and recommended $27 as its price target on September 25, 2023. Morgan Stanley upgraded its rating to Overweight for this stock on August 15, 2023, and upped its price target to $34. In a note dated October 05, 2022, Bryan Garnier initiated a Buy rating and provided a target price of $16 on this stock.
Pharvaris NV [PHVS] stock has fluctuated between $11.51 and $26.33 over the past year. Currently, Wall Street analysts expect the stock to reach $60 within the next 12 months. Pharvaris NV [NASDAQ: PHVS] shares were valued at $24.54 at the most recent close of the market. An investor can expect a potential return of 144.5% based on the average PHVS price forecast.
Analyzing the PHVS fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.8, Equity is -0.69 and Total Capital is -0.44. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 23.75 points at the first support level, and at 22.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 25.46, and for the 2nd resistance point, it is at 26.37.
Ratios To Look Out For
For context, Pharvaris NV’s Current Ratio is 12.86. As well, the Quick Ratio is 12.86, while the Cash Ratio is 7.98.
Transactions by insiders
Recent insider trading involved PENG LU, Officer, that happened on Jul 14 ’25 when 11307.0 shares were purchased. Officer, PENG LU completed a deal on Jul 11 ’25 to buy 351.0 shares. Meanwhile, Officer MORGAN CONN bought 26562.0 shares on Dec 02 ’24.
